Learn More
Description
The CH-L monoclonal antibody specifically binds to CD158b proteins. These proteins are 50-58 kDa type I glycoproteins that belong to the killer cell inhibitory receptor (KIR) family. They are also known as CD158b1 (Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2/KIR2DL2; NKAT-6; p58.2); CD158b2 (Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3/KIR2DL3; NKAT-2; p58.2); or CD158j (Killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2/KIR2DS2; NKAT-5; p50.2). CD158b molecules are composed of two extracellular Ig-like domains, a transmembrane region, and either long (76-84 amino acids) or short (39 amino acid) cytoplasmic tails. They are expressed on NK cells and subsets of TCR αβ+ cells or TCR γδ+ cells. Ligand- or CH-L antibody-bound CD158b1 or CD158b2 can reportedly inhibit cytolytic NK and T cell responses to various stimuli including certain target cells expressing MHC class I ligands encoded by HLA-C alleles (Cw 1, 3, 7 and 8). CD158j reportedly may enhance some cellular cytolytic responses.
Specifications
Specifications
| Antigen | CD158b |
| Applications | Flow Cytometry |
| Classification | Monoclonal |
| Clone | CH-L |
| Concentration | 0.5mg/mL |
| Conjugate | Unconjugated |
| Formulation | Aqueous buffered solution containing ≤0.09% sodium azide. |
| Host Species | Mouse |
| Purification Method | Affinity Purified |
| Quantity | 0.1 mg |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.